Hepatitis delta virus: the molecular basis of laboratory diagnosis.
Infection with hepatitis delta virus (HDV), a satellite virus of hepatitis B virus (HBV), is associated with severe and sometimes fulminant hepatitis. The traditional methods for the diagnosis of HDV infection, such as detection of serum anti-HD antibodies, are sufficient for the clinical diagnosis of delta infection. However, such techniques lack the sensitivity and specificity required to more accurately characterize the nature of HDV infection and to assess the efficacy of therapies. Recent improvements in molecular techniques, such as HDV RNA hybridization and RT-PCR, have provided increased diagnostic precision and a more thorough understanding of the natural course of HDV infection. These advances have enhanced the clinician's ability to accurately evaluate the stage of HDV infection, response to therapy, and occurrence of reinfection after orthotopic liver transplant. This review focuses on the recent advances in the understanding of the molecular biology of HDV and in the laboratory diagnosis of HDV infection.
Modahl
L E
LE
Department of Molecular Microbiology and Immunology, Howard Hughes Medical Institute, Los Angeles, CA, USA.
Lai
M M
MM
D006508:Hepatitis Antibodies / Q000097:blood*; D018963:Hepatitis Antigens / Q000097:blood; D006509:Hepatitis B; D003699:Hepatitis D / Q000175:diagnosis* / Q000517:prevention & control / Q000628:therapy; D019701:Hepatitis D, Chronic / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy; D003698:Hepatitis Delta Virus; D035923:Hepatitis delta Antigens; D006801:Humans; D012367:RNA, Viral / Q000097:blood*
D006508:Hepatitis Antibodies; D018963:Hepatitis Antigens; D035923:Hepatitis delta Antigens; D012367:RNA, Viral; C442244:hepatitis delta virus large antigen